Drug Type Interferons, Biosimilar |
Synonyms Interferon alpha-2b biosimilar (Reliance), ReliFeron |
Target |
Mechanism IFNAR agonists(Interferon alpha/beta receptor agonists), Immunostimulants, Innate antiviral immune response inducers |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date IN (01 Jan 2008), |
Regulation- |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Condylomata Acuminata | IN | 01 Jan 2008 | |
Hepatitis B | IN | 01 Jan 2008 | |
Hepatitis C | IN | 01 Jan 2008 | |
Kaposi Sarcoma | IN | 01 Jan 2008 | |
Melanoma | IN | 01 Jan 2008 |